Pancreatic Cancer Research

ResearcherSamsung Medical CenterActive in the last 2 years

Hye Jeong Jeong

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0024-1659; OpenAlex author ID A5108365655. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2022: 1 paper · 2023: 2 papers · 2024: none · 2025: 5 papers

Papers 8

  1. Synthetic data generation method improves risk prediction model for early tumor recurrence after surgery in patients with pancreatic cancer. Co-author DOI 10.1038/s41598-025-15800-4↗
  2. Implications of portal vein/superior mesenteric vein involvement in pancreatic cancer: A comprehensive correlation from preoperative radiological assessment to… Co-author DOI 10.1097/js9.0000000000002307↗
  3. The impact of distress at diagnosis in patients with pancreatic cancer undergoing pancreatectomy. Co-author DOI 10.1186/s12885-025-14365-9↗
  4. Prognostic Accuracy of ypTNM Stage in Patients with Pancreatic Cancer in the Era of Modern Neoadjuvant Therapy. Co-author DOI 10.1245/s10434-024-16792-7↗
  5. Impact of portal/superior mesenteric vein abutment angle on prognosis in pancreatic cancer: a single-center retrospective cohort study. Co-author DOI 10.4174/astr.2025.108.4.231↗
  6. Prognosis of pancreaticoduodenectomy in octogenarians for pancreatic ductal adenocarcinoma with propensity score matched analysis. Co-author DOI 10.1111/ans.18679↗
  7. Survival Benefit after Shifting from Upfront Surgery to Neoadjuvant Treatment in Borderline Resectable Pancreatic Cancer. Co-author DOI 10.3390/biomedicines11082302↗
  8. Pathological Response Predicts Survival after Pancreatectomy following Neoadjuvant FOLFIRINOX for Pancreatic Cancer. First author DOI 10.3390/cancers15010294↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jin Seok Heo · 8 shared papers, 2022–2025 · strength 1.78
  2. In Woong Han · 8 shared papers, 2022–2025 · strength 1.78
  3. Hongbeom Kim · 8 shared papers, 2022–2025 · strength 1.78
  4. Sang Hyun Shin · 8 shared papers, 2022–2025 · strength 1.78
  5. So Jeong Yoon · 7 shared papers, 2022–2025 · strength 1.54
  6. Hochang Chae · 5 shared papers, 2025 · strength 1.23
  7. Hyeong Seok Kim · 5 shared papers, 2025 · strength 1.23
  8. Hyun Jeong Jeon · 3 shared papers, 2022–2023 · strength 0.55
  9. Ji Hye Min · 2 shared papers, 2025 · strength 0.47
  10. Song Eun Yoon · 1 shared paper, 2025 · strength 0.25
  11. Seung Hyup Hyun · 1 shared paper, 2025 · strength 0.24

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.